Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

NCT02596074 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Usual Type Vulval Intraepithelial Neoplasia (uVIN)

Interventions

DRUG: Omiganan (CLS001) topical gel
DRUG: Vehicle topical gel

Sponsor

Maruho Co., Ltd.